Icad Number of Shares Shorted

ICAD Stock

USD 1.25 0.02 1.57%

Icad Inc fundamentals help investors to digest information that contributes to Icad's financial success or failures. It also enables traders to predict the movement of Icad Stock. The fundamental analysis module provides a way to measure Icad's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Icad stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Receivables Inventories

Icad Number of Shares Shorted Analysis

Icad's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

	2020	2021	2022	2023 (projected)
Interest Expense	476 K	141 K	126.9 K	130.24 K
Gross Profit	21.35 M	24.24 M	21.82 M	21.15 M

Interest Expense Gross Profit

Shares Shorted

Shorted by Public

by Institutions

More About Number of Shares Shorted | All Equity Analysis

Current Icad Number of Shares Shorted

266.46 K

Most of Icad's fundamental indicators, such as Number of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Icad Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Icad Number of Shares Shorted Driver Correlations

Understanding the fundamental principles of building solid financial models for Icad is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Icad's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Icad's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Icad's interrelated accounts and indicators.

Click cells to compare fundamentals

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Competition

Predict Icad

Based on the recorded statements, Icad Inc has 266.46 K of outstending shares currently sold short by investors. This is 91.67% lower than that of the Health Care Technology sector and 90.44% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 94.34% higher than that of the company.

Icad Number of Shares Shorted Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Icad's direct or indirect competition against its Number of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics of similar companies.

Icad is currently under evaluation in number of shares shorted category among related companies.

Icad Current Valuation Drivers

We derive many important indicators used in calculating different scores of Icad from analyzing Icad's financial statements. These drivers represent accounts that assess Icad's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Icad's important valuation drivers and their relationship over time.

	2018	2019	2020	2021	2022	2023 (projected)
Net Income Per Employee	(92.96 K)	(98.2 K)	(154.05 K)	(82.08 K)	(73.87 K)	(79.7 K)
Revenue Per Employee	264.13 K	227.1 K	259.8 K	245.53 K	282.36 K	301.9 K
Average Assets	29.1 M	39.29 M	47.28 M	67.5 M	60.75 M	54.23 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	(7.76 M)	(12.05 M)	(16.52 M)	(10.55 M)	(9.49 M)	(10.24 M)
Earnings Before Interest Taxes and Depreciation Amortization USD	(7.76 M)	(12.05 M)	(16.52 M)	(10.55 M)	(9.49 M)	(10.24 M)
Earnings before Tax	(8.97 M)	(13.51 M)	(17.57 M)	(11.24 M)	(10.12 M)	(10.92 M)
Average Equity	9.72 M	7.18 M	24.36 M	50.18 M	45.16 M	36.14 M
Enterprise Value	61.34 M	153.32 M	290.71 M	146.27 M	168.21 M	153.37 M
Free Cash Flow	(4.17 M)	(7.4 M)	(7.45 M)	(9.97 M)	(8.97 M)	(9.21 M)
Invested Capital	9.5 M	20.54 M	11.15 M	5.06 M	5.82 M	7.48 M
Invested Capital Average	5.82 M	16.51 M	10.77 M	8.18 M	9.4 M	9.4 M
Market Capitalization	62.06 M	150.42 M	303.51 M	180.79 M	207.91 M	179.39 M
Tangible Asset Value	21.82 M	32.2 M	46.33 M	53.15 M	61.12 M	50.91 M
Working Capital	7.97 M	10.36 M	25.55 M	35.34 M	40.65 M	43.85 M

Icad Fundamentals

	Return On Equity	(0.34) %
	Return On Asset	(0.15) %
	Profit Margin	(0.50) %
	Operating Margin	(0.50) %
	Current Valuation	20.38 M
	Shares Outstanding	25.45 M
	Shares Owned by Insiders	7.31 %
	Shares Owned by Institutions	45.33 %
	Number of Shares Shorted	266.46 K
	Price to Earning	(8.32) X
	Price to Book	1.11 X
	Price to Sales	1.56 X
	Revenue	33.64 M
	Gross Profit	24.56 M
	EBITDA	(11.15 M)
	Net Income	(11.24 M)
	Cash and Equivalents	27.18 M
	Cash per Share	1.07 X
	Total Debt	3.16 M
	Debt to Equity	0.08 %
	Current Ratio	3.19 X
	Book Value Per Share	1.49 X
	Cash Flow from Operations	(9.41 M)
	Short Ratio	2.06 X
	Earnings Per Share	(0.52) X
	Price to Earnings To Growth	(0.56) X
	Target Price	5.0
	Number of Employees	136
	Beta	1.21
	Market Capitalization	32.32 M
	Total Asset	62.19 M
	Retained Earnings	(242.03 M)
	Working Capital	13.49 M
	Current Asset	27.77 M
	Current Liabilities	14.28 M
	Z Score	1.8
	Net Asset	62.19 M

About Icad Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Icad Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. Icad operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 136 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Global Correlations Now

Global Correlations

Find global opportunities by holding instruments from different markets

All Next

Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Icad Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Please see Icad Piotroski F Score and Icad Altman Z Score analysis. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Icad Stock analysis

When running Icad Inc price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.

	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Global Correlations Find global opportunities by holding instruments from different markets
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.52)

Revenue Per Share

1.163

Quarterly Revenue Growth

(0.32)

Return On Assets

(0.15)

Return On Equity

(0.34)

The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine Icad value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Accounts Payable	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Shareholders Equity	Total Liabilities	Current Liabilities	Tax Liabilities
Accounts Payable		-0.01	0.65	0.59	-0.3	-0.36	-0.51	0.2	-0.36	-0.06	-0.33
Total Assets	-0.01		0.42	0.53	0.12	0.49	0.72	0.84	0.33	0.62	-0.07
Current Assets	0.65	0.42		0.99	-0.47	-0.28	-0.19	0.67	-0.4	0.1	-0.39
Cash and Equivalents	0.59	0.53	0.99		-0.41	-0.19	-0.1	0.74	-0.32	0.13	-0.4
Total Debt	-0.3	0.12	-0.47	-0.41		0.87	0.31	-0.43	0.95	0.52	-0.15
Debt Current	-0.36	0.49	-0.28	-0.19	0.87		0.59	-0.02	0.92	0.67	-0.07
Deferred Revenue	-0.51	0.72	-0.19	-0.1	0.31	0.59		0.43	0.52	0.68	0.25
Shareholders Equity	0.2	0.84	0.67	0.74	-0.43	-0.02	0.43		-0.24	0.24	0.0
Total Liabilities	-0.36	0.33	-0.4	-0.32	0.95	0.92	0.52	-0.24		0.67	-0.12
Current Liabilities	-0.06	0.62	0.1	0.13	0.52	0.67	0.68	0.24	0.67		-0.18
Tax Liabilities	-0.33	-0.07	-0.39	-0.4	-0.15	-0.07	0.25	0.0	-0.12	-0.18

Icad Number of Shares Shorted

Icad Number of Shares Shorted Analysis

Current Icad Number of Shares Shorted

Icad Number of Shares Shorted Driver Correlations

Icad Number of Shares Shorted Peer Comparison

Icad Current Valuation Drivers

Icad Fundamentals

About Icad Fundamental Analysis

Be your own money manager

Did you try this?

Run Global Correlations Now

Global Correlations

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Icad Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY